Definitive Contract 75D30119C05596

Award Date 7/1/19
Potential Completion Date 6/30/24
Potential Value $421K
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Collins, CO 80521, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,742.00 firm fixed-price purchase order contract to Bio-Rad Laboratories, Inc. Life Science Group Division for the provision of laboratory supplies. The contract has an ultimate completion date of September 21, 2024. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostic products. As the parent company, Bio-Rad Laboratories, Inc. holds several significant federal Indefinite Delivery...
This $95,000.00 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Bio-Rad Laboratories, Inc. Life Science Group Division for LABORATORY SUPPLIES. The contract has no set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics equipment, reagents, and consumables. It has established relationships with multiple federal agencies, including the CDC, through prime contract...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Bio-Rad Laboratories, Inc. Life Science Group Division, a for-profit manufacturer of biotechnology products and laboratory equipment. The $103,398.60 firm-fixed-price purchase order is for the delivery of a DDPCR SYSTEM. No set-aside designation was indicated. Bio-Rad Laboratories holds a 5-year, $1 billion blanket purchase agreement with the National Institutes of...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc., a global leader in developing and manufacturing products for life science research and clinical diagnostics. The $88,935.00 contract is for the provision of Bio-Rad reagents, with an ultimate completion date of September 25, 2020. The contract was a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. Bio-Rad Laboratories, Inc. has established several...
This is a $24,995.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract does not have a set-aside designation. The award is for the provision of unspecified products and services related to Bio-Rad's capabilities in providing laboratory equipment, reagents, and consumables for biomedical research and clinical...
The Centers for Disease Control and Prevention (CDC) awarded a $22,944.00 firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. for PCR system equipment maintenance. The contract has an ultimate completion date of April 22, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics, and serves as a prime contractor to numerous federal agencies, including the National Institutes of Health (NIH),...
This federal contract award, valued at $63,189.00, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is for the provision of BIO RAD SUPPLIES and has a completion date of September 30, 2023. No set-aside designation was used. Bio-Rad Laboratories, Inc. is an experienced federal contractor, holding several significant...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Bio-Rad Laboratories, Inc., Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The contract is for a BIO-RAD MAINTENANCE PLAN with a potential value of $157,886.08 and a completion date of August 18, 2024. The contract was awarded on August 19, 2019 with no set-aside designation. Bio-Rad Laboratories, Inc. is an experienced federal...
This is a $124,117.10 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Bio Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products. The contract is for the supply of unspecified products and services, and does not have a set-aside designation. Bio Rad Laboratories Inc. is a subsidiary of the parent company Bio-Rad Laboratories, Inc., which serves as a prime contractor on numerous federal...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. Life Science Group Division for preventative maintenance services on Bio-Rad equipment. The contract has a ceiling value of $86,790.00 and a period of performance through June 30, 2019. Bio-Rad Laboratories is a global life sciences company that provides a wide range of research instruments, reagents, and related services to federal agencies including...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $421,384.80 firm fixed-price definitive contract to Bio-Rad Laboratories, Inc. Life Science Group Division for the maintenance of laboratory equipment at the NCEZID (National Center for Emerging and Zoonotic Infectious Diseases) in Fort Collins, Colorado. The contract runs from July 1, 2019, to June 30, 2024. Bio-Rad Laboratories is a for-profit manufacturer of life science research products and clinical diagnostic equipment that has previously provided specialized biotechnology solutions to federal agencies, including the NIH, CDC, and FDA, through prime contracts and subcontracts. This contract does not have a set-aside designation.

Generated 3/22/24, 2:15 AM